Livento Group, Inc.
NUGN
$0.0018
$0.00015.88%
| Weiss Ratings | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | D- | |||
| Rating Factors | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.78 | |||
| Price History | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.00% | |||
| 30-Day Total Return | -40.00% | |||
| 60-Day Total Return | -55.00% | |||
| 90-Day Total Return | -72.31% | |||
| Year to Date Total Return | -57.14% | |||
| 1-Year Total Return | -82.86% | |||
| 2-Year Total Return | -97.46% | |||
| 3-Year Total Return | -95.70% | |||
| 5-Year Total Return | 50.00% | |||
| 52-Week High % Change | -95.74% | |||
| 52-Week Low % Change | 54.55% | |||
| Price | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.04 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Feb 18, 2025 | |||
| 52-Week High Price (Date) | Aug 09, 2024 | |||
| Valuation | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.41M | |||
| Enterprise Value | 1.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -100.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.71 | |||
| Price/Book (Q) | 0.03 | |||
| Enterprise Value/Revenue (TTM) | 0.79 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | 1.00 | |||
| Enterprise Value/EBIT | -1.01 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 776.26M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 980 432 8241 | |||
| Address | 17 State Street New York, NY 10004 | |||
| Website | www.liventogroup.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -77.51% | |||
| Profit Margin | 0.14% | |||
| Management Effectiveness | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.93% | |||
| Return on Equity | 0.01% | |||
| Income Statement | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.89M | |||
| Total Revenue (TTM) | 1.89M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -665.00K | |||
| EBITDA (TTM) | 1.49M | |||
| EBIT (TTM) | -1.46M | |||
| Net Income (TTM) | 2.80K | |||
| Net Income Avl. to Common (TTM) | 2.80K | |||
| Total Revenue Growth (Q YOY) | -10.06% | |||
| Earnings Growth (Q YOY) | 65.28% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 84.38% | |||
| Balance Sheet | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 3.22M | |||
| Total Preferred Equity (Q) | 0.04 | |||
| Total Equity (Q) | 43.86M | |||
| Current Ratio (Q) | 5.401 | |||
| Book Value Per Share (Q) | $0.06 | |||
| Total Assets (Q) | 47.95M | |||
| Total Current Liabilities (Q) | 596.20K | |||
| Total Debt (Q) | 26.40K | |||
| Total Liabilities (Q) | 4.09M | |||
| Total Common Equity (Q) | 43.81M | |||
| Cash Flow | NUGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -631.40K | |||
| Cash from Financing (TTM) | 529.50K | |||
| Net Change in Cash (TTM) | -186.90K | |||
| Levered Free Cash Flow (TTM) | -719.40K | |||
| Cash from Operations (TTM) | -81.30K | |||
